Microglial pathological synaptic pruning in epilepsy: pathophysiology and therapeutic potential

Area of Science:

• Neuroscience
• Immunology
• Epilepsy Research

Background:

• Epilepsy impacts 70 million globally, with one-third resistant to current drugs.
• Existing epilepsy treatments focus on neurons, neglecting non-neuronal cells like microglia.
• Microglia, central nervous system immune cells, regulate neuronal survival and circuit function via synaptic pruning.

Purpose of the Study:

• To review microglial involvement in pathological synaptic pruning in epilepsy.
• To explore signaling pathways driving aberrant pruning in epilepsy.
• To assess therapeutic targeting of microglia for drug-resistant epilepsy.

Main Methods:

• Review of recent scientific literature on microglia and epilepsy.
• Analysis of signaling pathways involved in microglial synaptic pruning.
• Evaluation of potential therapeutic strategies targeting microglia.

Main Results:

• Microglia dysregulate synaptic pruning in epilepsy, preferentially eliminating inhibitory synapses.
• This leads to excitatory/inhibitory imbalance, network hyperexcitability, and seizures.
• Specific signaling pathways driving pathological pruning have been identified.

Conclusions:

• Microglia play a critical role in epilepsy pathogenesis through aberrant synaptic pruning.
• Targeting microglial pathways presents a novel therapeutic avenue for drug-resistant epilepsy.
• Future treatments may move beyond neuron-centric approaches to include immune cell modulation.